RIFAMPIN for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 19 adverse event reports in the FDA FAERS database where RIFAMPIN was used for Psoriasis.
Most Reported Side Effects for RIFAMPIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 1,238 | 9.3% | 288 | 518 |
| Drug reaction with eosinophilia and systemic symptoms | 1,049 | 7.9% | 53 | 625 |
| Drug interaction | 735 | 5.5% | 46 | 333 |
| Pyrexia | 735 | 5.5% | 48 | 468 |
| Acute kidney injury | 684 | 5.1% | 133 | 489 |
| Drug-induced liver injury | 684 | 5.1% | 179 | 211 |
| Off label use | 640 | 4.8% | 76 | 281 |
| Condition aggravated | 597 | 4.5% | 65 | 249 |
| Nausea | 572 | 4.3% | 20 | 322 |
| Paradoxical drug reaction | 570 | 4.3% | 23 | 226 |
| Drug resistance | 539 | 4.0% | 53 | 104 |
| Vomiting | 538 | 4.0% | 23 | 332 |
| Product use in unapproved indication | 481 | 3.6% | 42 | 101 |
| Rash | 478 | 3.6% | 28 | 262 |
| Thrombocytopenia | 429 | 3.2% | 90 | 278 |
Other Indications for RIFAMPIN
Tuberculosis (2,323)
Product used for unknown indication (1,281)
Pulmonary tuberculosis (1,192)
Mycobacterium avium complex infection (787)
Staphylococcal infection (439)
Disseminated tuberculosis (438)
Infection (405)
Device related infection (354)
Endocarditis (296)
Osteitis (237)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)